Search Count: 5
All
Selected
 |
Crystal Structure Of Human Pde1B Catalytic Domain In Complex With Inhibitor 16J (6-(4-Methoxybenzyl)-9-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-8,9,10,11-Tetrahydropyrido[4',3':4,5]Thieno[3,2-E][1,2,4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2017-04-26 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, MG, 8HM |
 |
Crystal Structure Of Human Pde1B Catalytic Domain In Complex With Inhibitor 3 (6-(4-Chlorobenzyl)-8,9,10,11-Tetrahydrobenzo[4,5]Thieno[3,2-E][1,2,4]Triazolo[1,5-C]Pyrimidin-5(6H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2017-04-26 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, MG, 8HP |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2017-04-26 Classification: Hydrolase/Hydrolase Inhibitor Ligands: 8Q7, ZN, MG |
 |
Co-Crystal Structure Of Compound 3 (4-Hydroxy-6-[2-(7-Hydroxy-2-Oxo-4-Phenyl-2H-Chromen-6-Yl)Ethyl]Pyridazin-3(2H)-One) And Fad Bound To Human Daao At 2.4A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2014-07-16 Classification: oxidoreductase/oxidoreductase inhibitor Ligands: FAD, 31T, K |
 |
Co-Crystal Structure Of Compound 2 (3-(7-Hydroxy-2-Oxo-4-Phenyl-2H-Chromen-6-Yl)Propanoic Acid) And Fad Bound To Human Daao At 2.85A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2014-07-16 Classification: oxidoreductase/oxidoreductase inhibitor |